X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE GSK PHARMA SUVEN LIFE/
GSK PHARMA
 
P/E (TTM) x 13.9 56.9 24.4% View Chart
P/BV x 3.3 10.2 32.4% View Chart
Dividend Yield % 0.5 1.2 42.6%  

Financials

 SUVEN LIFE   GSK PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
GSK PHARMA
Mar-17
SUVEN LIFE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2293,838 6.0%   
Low Rs1512,637 5.7%   
Sales per share (Unadj.) Rs42.7354.2 12.1%  
Earnings per share (Unadj.) Rs6.939.8 17.2%  
Cash flow per share (Unadj.) Rs8.542.9 19.9%  
Dividends per share (Unadj.) Rs1.0030.00 3.3%  
Dividend yield (eoy) %0.50.9 56.9%  
Book value per share (Unadj.) Rs52.4236.9 22.1%  
Shares outstanding (eoy) m127.2884.70 150.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.49.1 48.6%   
Avg P/E ratio x27.781.4 34.0%  
P/CF ratio (eoy) x22.275.5 29.5%  
Price / Book Value ratio x3.613.7 26.5%  
Dividend payout %14.675.4 19.3%   
Avg Mkt Cap Rs m24,158274,216 8.8%   
No. of employees `0001.04.7 21.6%   
Total wages/salary Rs m5224,830 10.8%   
Avg. sales/employee Rs Th5,349.76,387.0 83.8%   
Avg. wages/employee Rs Th513.51,028.3 49.9%   
Avg. net profit/employee Rs Th858.1717.1 119.7%   
INCOME DATA
Net Sales Rs m5,43530,000 18.1%  
Other income Rs m211728 29.0%   
Total revenues Rs m5,64630,728 18.4%   
Gross profit Rs m1,2914,190 30.8%  
Depreciation Rs m214263 81.4%   
Interest Rs m570-   
Profit before tax Rs m1,2314,655 26.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m3591,744 20.6%   
Profit after tax Rs m8723,368 25.9%  
Gross profit margin %23.714.0 170.0%  
Effective tax rate %29.237.5 77.8%   
Net profit margin %16.011.2 142.9%  
BALANCE SHEET DATA
Current assets Rs m4,91716,742 29.4%   
Current liabilities Rs m1,1867,202 16.5%   
Net working cap to sales %68.631.8 215.9%  
Current ratio x4.12.3 178.3%  
Inventory Days Days6252 119.9%  
Debtors Days Days3121 148.1%  
Net fixed assets Rs m3,1548,635 36.5%   
Share capital Rs m127847 15.0%   
"Free" reserves Rs m6,54319,222 34.0%   
Net worth Rs m6,67020,069 33.2%   
Long term debt Rs m25910 2,593.0%   
Total assets Rs m8,15730,038 27.2%  
Interest coverage x22.7NM-  
Debt to equity ratio x00 7,801.8%  
Sales to assets ratio x0.71.0 66.7%   
Return on assets %11.411.2 101.5%  
Return on equity %13.116.8 77.9%  
Return on capital %18.625.5 73.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,996528 946.3%   
Fx outflow Rs m9597,193 13.3%   
Net fx Rs m4,037-6,665 -60.6%   
CASH FLOW
From Operations Rs m1,0882,360 46.1%  
From Investments Rs m-3,1073,008 -103.3%  
From Financial Activity Rs m-300-5,108 5.9%  
Net Cashflow Rs m-2,319260 -890.7%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.0 10.2 -  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 102,036 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


May 22, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS